MedPath

TO DETERMINE WHETHER CLINICAL OUTCOME IS BETTER WHEN TREATMENT IS DECIDED ON BASIS OF AGE AND FOLLICULAR STIMULATING HORMONE AS GUIDE TO TREATMENT OR ANTIMULLERIAN HORMONE VALUES IN IN VITRO FERTILISATION PATIENTS.

Not Applicable
Conditions
Health Condition 1: null- INFERTILITY
Registration Number
CTRI/2012/11/003139
Lead Sponsor
nil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

patients on IST cycle ART

both ovaries visualised

severe endometriosis excluded

Exclusion Criteria

oncology patients

severe endometriosis

AMH 0.5

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinical pregnancy per cycle startedTimepoint: APRIL 2012 - APRIL 2014
Secondary Outcome Measures
NameTimeMethod
number of oocytes yield <br/ ><br>cycle cancellation to cycle yield <br/ ><br>et percycle started <br/ ><br>ohss leading to cycle cancellationTimepoint: 6weeks
© Copyright 2025. All Rights Reserved by MedPath